We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$11M
Cap. Flow
-$5.71M
Cap. Flow %
-3.55%
Top 10 Hldgs %
44.28%
Holding
361
New
80
Increased
31
Reduced
55
Closed
58
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
2.1 quarters
Top 20 Avg Time Held Equity + Options
2.3 quarters
Avg Time Held Equity only
3.9 quarters
Top 10 Avg Time Held Equity only
3.5 quarters
Top 20 Avg Time Held Equity only
3.3 quarters

Top Buys

Rank Stock Value
1
CPRI icon
Capri Holdings
CPRI
+$1.13M
2
BIIB icon
Biogen
BIIB
+$803K
3
ABBV icon
AbbVie
ABBV
+$773K
4
MGM icon
MGM Resorts International
MGM
+$610K
5
KRNY icon
Kearny Financial
KRNY
+$521K

Sector Composition

Rank Sector Weight
1 Financials 33.05%
2 Miscellaneous 33%
3 Healthcare 14.28%
4 Consumer Discretionary 7.06%
5 Technology 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SWN icon
251
CALL
DELISTED
Southwestern Energy Company
SWN
– –
-20,000
Closed -$464K –
LL icon
252
CALL
DELISTED
LL Flooring Holdings, Inc.
LL
– –
-10,000
Closed -$308K –
CMLS icon
253
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
– –
-3,125
Closed -$62K –
CBAY icon
254
DELISTED
Cymabay Therapeutics
CBAY
– –
-20,000
Closed -$138K –
MDRX
255
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-10,000
Closed -$120K –
AGRX
256
DELISTED
Agile Therapeutics
AGRX
– –
-5
Closed -$93K –
TWTR
257
DELISTED
Twitter, Inc.
TWTR
– –
-8,126
Closed -$332K –
PRCP
258
DELISTED
Perceptron Inc
PRCP
– –
-10,000
Closed -$135K –
VER
259
DELISTED
VEREIT, Inc.
VER
– –
-4,000
Closed -$197K –
GNMX icon
260
DELISTED
Aevi Genomic Medicine Inc
GNMX
– –
-32,500
Closed -$262K –
NLST
261
DELISTED
Netlist, Inc.
NLST
– –
-25,000
Closed -$15K –
JUNO
262
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-5,000
Closed -$303K –
KITE
263
DELISTED
Kite Pharma, Inc.
KITE
– –
-5,000
Closed -$288K –
NVDQ icon
264
DELISTED
Novadaq Technologies Inc.
NVDQ
– –
-30,000
Closed -$487K –
DYAX
265
DELISTED
DYAX CORPORATION
DYAX
– –
-20,000
Closed -$335K –
SD icon
266
DELISTED
SANDRIDGE ENERGY, INC.
SD
– –
-75,200
Closed -$134K –
KYTH
267
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
– –
-5,000
Closed -$251K –
PCYC
268
DELISTED
PHARMACYCLICS INC
PCYC
– –
-7,000
Closed -$1.79M –
BAXS
269
DELISTED
BAXANO SURGICAL INC COM STK (DE)
BAXS
– –
-25,000
Closed – –
MNC
270
DELISTED
MONACO COACH CORP
MNC
– –
-50,000
Closed – –
JMBA
271
DELISTED
Jamba, Inc.
JMBA
– –
-20,000
Closed -$294K –
NDRM
272
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
– –
-35,000
Closed -$470K –
KKD
273
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
– –
-10,000
Closed -$200K –

Similar funds

E.E. Geduld's Q2 2015 Portfolio in Review

As of Q2 2015, E.E. Geduld held 361 positions worth $161M, up 7.3% from $150M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

E.E. Geduld withdrew a net $5.71M in Q2 2015, closing 58 positions and reducing 55 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $1.79M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, E.E. Geduld opened a new position in Capri Holdings worth $842K.

  • E.E. Geduld's largest Q2 2015 buy was Capri Holdings: 20,000 shares worth $842K.
  • E.E. Geduld added most to Blackstone Mortgage Trust in Q2 2015, an estimated $355K increase.
  • E.E. Geduld's biggest Q2 2015 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.34M.
  • E.E. Geduld fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $1.79M.
  • E.E. Geduld's ten largest holdings make up 44% of its $161M portfolio in Q2 2015.
  • E.E. Geduld opened 80 new positions and closed 58 in Q2 2015.
  • E.E. Geduld's portfolio value rose 7.3% quarter-over-quarter to $161M.

Based on E.E. Geduld's 13F filing for Q2 2015, filed 7 Aug 2015.